Definitive Contract 75F40121C00090
Award Date
8/6/21
Potential Completion Date
3/31/25
Potential Value
$5M
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,038,686.00, was issued by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) to address the ongoing growth in continuous manufacturing within cell lines. The award is part of the FDA's Broad Agency Announcement (BAA) program, which funds extramural research and development to support regulatory science and innovation. The BAA solicitation did not have a set-aside designation. Through this contract, MIT will...
This $4,714,475.00 definitive, firm-fixed-price federal contract was awarded by the U.S. Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) to conduct research and development on mechanistic modeling and process analytical technology for exosome production. The work is being performed in Cambridge, Massachusetts and will be completed by September 29, 2026. This contract was competitively awarded and is not designated as a set-aside. The original solicitation...
This is a $4,999,325.00 federal contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) to conduct research on controlled protein capture via continuous crystallization and precipitation for monoclonal antibody manufacturing. The contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science and does not have a set-aside designation. The contract involves research and development activities to advance...
This federal contract, awarded by the Food and Drug Administration (FDA), provides $2,565,626.00 to the Massachusetts Institute of Technology (MIT) to conduct research and development on "Technologies to Enable Continuous Production of RAAV from SF9/Baculovirus Culture". The contract has no set-aside designation. The work is being performed under the FDA's Broad Agency Announcement for Advanced Regulatory Science, which seeks proposals across eight areas of regulatory science to...
This federal contract award, valued at $11,348,590.00, was issued by the National Institutes of Health (NIH) to the Massachusetts Institute of Technology (MIT) under an Other Transaction Agreement. The contract, titled "ARPA-H ADAPT AURORA: AI-DRIVEN UNDERSTANDING OF RESPONSE OPTIMIZATION AND RESISTANCE ASSESSMENT," is focused on advanced research and development in artificial intelligence and related technologies. The award does not have a set-aside designation, indicating MIT's broad...
This is a federal contract award to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers (FFRDCs), to provide systems engineering and technical acquisitions support services to the U.S. Food and Drug Administration (FDA). The contract has a ceiling value of $5,859,996.00 and runs from September 30, 2015 to December 21, 2016. It is a Cost Plus Fixed Fee contract type. The Mitre Corporation has been awarded multiple federal contracts...
This federal contract award was issued by the Food and Drug Administration (FDA) to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers (FFRDCs). The contract, valued at $1,253,650.78, is a cost-plus-fixed-fee delivery order for strategic engineering support, data standards, and harmonization services for the Office of the Chief Scientist and the Office of Health Informatics. The contract does not have a set-aside designation. The...
This federal contract award, valued at $4,835,002, was made by the Food and Drug Administration (FDA) to The Mitre Corporation, a not-for-profit organization that operates federally funded research and development centers. The contract is for system engineering and acquisitions support for the FDA's Office of Acquisitions and Grants Services (OAGS). This is a cost-plus-fixed-fee delivery order contract with a period of performance ending on September 29, 2017. The contract was not set aside...
This is a federal contract award from the Food and Drug Administration (FDA) to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers (FFRDCs). The purpose of this $1,196,504.21 cost-plus-fixed-fee contract is to provide data harmonization and strategic standards support for the FDA's Office of Data, Analytics, and Research (ODAR), Health Informatics (HI) division. The contract has no set-aside designation. This contract is not...
The Food and Drug Administration (FDA) awarded a $4,567,087.00 cost-plus-fixed-fee delivery order contract to The Mitre Corporation, a non-profit organization, to support the FDA's Chief Data Office for real-world evidence and data agile analytics of specialized data sets. This contract, which has no set-aside designation, is part of the FDA's response to the Coronavirus (COVID-19) pandemic. The Mitre Corporation, a long-standing partner to federal agencies, will leverage its expertise in...